A reception was held in Boston this week to announce a $1 million donation from the Ansin family, owners of Channel 7,<a class="excerpt-read-more" href=" More ...

On the way to creating a fully internal cochlear implant, a multidisciplinary team of researchers at MIT, Massachusetts Eye and Ear, Harvard Medical School, and Columbia University has produced an ...

(Bloomberg) — Novo Nordisk A/S’ (NVO) best-selling diabetes and weight-loss drugs Ozempic and Wegovy appear to be associated with a higher risk of a rare form of vision loss, according to an ...

The relatively small study examined the records of Massachusetts Eye and Ear patients. The low number of cases of the eye condition in people who took the drugs – 37 between both groups ...

New research led by the Massachusetts Eye and Ear Hospital (Mass Eye and Ear) found that semaglutide use was associated with nonarteritic anterior ischemic optic neuropathy (NAION), or ‘eye ...

Researchers at Massachusetts Eye and Ear hospital found that people who were overweight or obese who were prescribed semaglutide, the active ingredient in both drugs, were seven times more likely ...

Two Boston hospitals are among the 20 best in the country, according to the U.S. News and World Report’s annual list.

After hearing anecdotes of patients on the diabetes and obesity drugs experiencing nonarteritic anterior ischemic optic neuropathy, or NAION, researchers at Massachusetts Eye and Ear analyzed data ...

For the analysis, the researchers obtained data from more than 16,000 patients treated at Massachusetts Eye and Ear, a Harvard-affiliated hospital. They focused on 710 and 979 patients who had ...

So they evaluated nearly 17,000 patients seen by neuro-ophthalmologists at Massachusetts Eye and Ear between December 2017 and November 2023. Patients who were taking either Ozempic or Wegovy were ...